Home > Introduction > Board Members
Prof Raj Thampuran
Prof Raj Thampuran is Managing Director of A*STAR and Chairman of the ETPL Board. He joined A*STAR in 2000 and has held various executive positions in the Electronics, Engineering and Chemicals clusters, Institute of High Performance Computing, and in planning and policy. Prof Raj has a PhD in Materials Science, and attended the Advanced Management Programme in INSEAD (Fontainebleau). He received the National Academic Award in 1998 and a Public Administration Medal (Bronze) in 2007.
Chief Executive Officer
Philip Lim is CEO of ETPL. He was with the Ministry of Defence (MINDEF) as Brigadier General and Head of Joint Logistics, overseeing all logistics and engineering matters. Philip has an MBA from the National University of Singapore, a Master of Science from Cranfield Institute of Technology and attended the Harvard Business School’s Programme for Management Development. Philip was awarded the Commendation Medal (Military) in 1995 and the Public Administration Medal, Silver (Military) in 2004.
Group Chief Operating Officer
Abel Ang is the Chief Operating Officer of Accuron, where he has overall responsibility for Accuron’s Medical Device activities. He has previously served as Senior Advisor to the CEO of Greatbatch, providing commercialisation advice on medical device technologies into healthcare markets. Prior to Greatbatch, Abel was President, Asia Pacific for Hill-Rom and also served as its Chief Technology Officer. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s Biomedical Division. He currently serves on the Board of Economic Development Innovations in Singapore, and the Boards of the following Accuron Medical Device Operating companies: Dornier Medizintechnik, Veredus Pte Ltd, Advanced Materials Technologies (AMT) Pte Ltd and Aslan Pharmaceuticals Ltd.
Dr Carl Firth
Founder & CEO
Dr Carl Firth is CEO of ASLAN Pharmaceuticals, which develops novel medicines for global markets. He was previously Head of Asia Healthcare at Bank of America Merrill Lynch, and has more than five years of pharmaceutical R&D experience. Dr Firth has held positions in other commercial areas in the UK, including acquisitions, licensing and competitive intelligence. He holds a PhD from Cambridge University in Molecular Biology and an Executive MBA from London Business School.
Mr Jean-Luc Butel
Global Healthcare Advisor and President, K8 Global Pte Ltd,
Senior Advisor, McKinsey & Co.
Prior to his appointment as Senior Advisor in McKinsey & Co. in July 2015, Jean-Luc Butel was President at Baxter Healthcare (Asia) Pte Ltd and was responsible for leading its international operations. He was also Global Healthcare Advisor and President of K8 Global Pte Ltd, and was previously Executive Vice President and Group President of International Operations at Medtronic Inc. overseeing Medtronic's operations outside of the United States. He was responsible for managing and driving all business activities for Medtronic in the Asia Pacific region. He has been Non-Executive and Independent Director at Biosensors International Group, Ltd. since March 2, 2015. He serves as a Director of Singapore Economic Development Board.
Mr Kevin Wong
Bosons Capital Pte Ltd
Mr. Kevin Wong is the Chairman of Bosons Capital Pte Ltd. He was the Group CEO of Keppel Land Limited for 13 years. Keppel Land is one of the largest listed real estate companies in Singapore and has investments and developments in over 10 countries in Asia. Prior to joining Keppel Land, Mr Wong was with various companies in related industries in the US, UK, and Hong Kong. Mr Wong was the Chairman of Alpha Investment Partners Limited and Deputy Chairman of K-REIT Asia Management Limited, both are fund management companies with over S$8.5 billion and S$6.5 billion assets under management respectively.